Showing results (1291-1300 of 8,793) with videos related to

Sort By:
Pageof 880
Pediatric Blood & Cancer|January 18, 2007
The future of pediatric cancer and complex diseases: aren't they all?Stephen Chanock, Meredith Yeager
Pediatric Blood & Cancer|January 18, 2007
Incidence of childhood cancer in Switzerland: the Swiss Childhood Cancer RegistryG Michel, N X von der Weid, M Zwahlen, et al.
Pediatric Blood & Cancer|April 10, 2007
Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1HMwe Mwe Chao, John E Levine, James L Ferrara, et al.
Pediatric Blood & Cancer|April 4, 2007
Colorectal carcinoma in children and adolescents: the experience of the Istituto Nazionale Tumori of Milan, ItalyAndrea Ferrari, Alessia Rognone, Michela Casanova, et al.
Pediatric Blood & Cancer|October 22, 2008
Arterial spin-labeled perfusion combined with segmentation techniques to evaluate cerebral blood flow in white and gray matter of children with sickle cell anemiaKathleen J Helton, Amir Paydar, John Glass, et al.
Pediatric Blood & Cancer|October 22, 2008
Renal cell carcinoma in the pediatric population: Results from the California Cancer RegistryJonathan Silberstein, Julia Grabowski, Sidney L Saltzstein, et al.
Pediatric Blood & Cancer|October 22, 2008
Treatment of the X-linked lymphoproliferative, Griscelli and Chédiak-Higashi syndromes by HLH directed therapyHelena Trottestam, Karin Beutel, Marie Meeths, et al.
Pediatric Blood & Cancer|September 1, 2007
Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study GroupAkira Shimada, Tomohiko Taki, Ken Tabuchi, et al.
Pediatric Blood & Cancer|September 1, 2007
Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemiaJessica R Roberson, Mihaela Onciu, Stanley Pounds, et al.
Pediatric Blood & Cancer|March 21, 2009
Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximabKotoe Iesato, Naoki Hatakeyama, Masaki Yamamoto, et al.
Pageof 880